NDC 67296-1237

Truvada

Truvada

Truvada is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redpharm Drug, Inc.. The primary component is Emtricitabine; Tenofovir Disoproxil Fumarate.

Product ID67296-1237_4f4268c2-42ab-49fa-e054-00144ff88e88
NDC67296-1237
Product TypeHuman Prescription Drug
Proprietary NameTruvada
Generic NameTruvada
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2004-08-02
Marketing CategoryNDA / NDA
Application NumberNDA021752
Labeler NameRedPharm Drug, Inc.
Substance NameEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 67296-1237-3

3 TABLET, FILM COATED in 1 BOTTLE (67296-1237-3)
Marketing Start Date2004-08-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67296-1237-4 [67296123704]

Truvada TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021752
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-02

NDC 67296-1237-3 [67296123703]

Truvada TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021752
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-08-02

Drug Details

Active Ingredients

IngredientStrength
EMTRICITABINE200 mg/1

OpenFDA Data

SPL SET ID:4f4268c2-42aa-49fa-e054-00144ff88e88
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 476556
  • UPC Code
  • 0367296123746
  • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

    NDC Crossover Matching brand name "Truvada" or generic name "Truvada"

    NDCBrand NameGeneric Name
    35356-070Truvadaemtricitabine and tenofovir disoproxil fumarate
    50090-0870Truvadaemtricitabine and tenofovir disoproxil fumarate
    52959-969Truvadaemtricitabine and tenofovir disoproxil fumarate
    53808-0805Truvadaemtricitabine and tenofovir disoproxil fumarate
    61919-669TRUVADAemtricitabine and tenofovir disoproxil fumarate
    61958-0701Truvadaemtricitabine and tenofovir disoproxil fumarate
    61958-0703Truvadaemtricitabine and tenofovir disoproxil fumarate
    61958-0704Truvadaemtricitabine and tenofovir disoproxil fumarate
    61958-0705Truvadaemtricitabine and tenofovir disoproxil fumarate
    63629-7581Truvadaemtricitabine and tenofovir disoproxil fumarate
    67296-1237TruvadaTruvada
    68071-2112Truvadaemtricitabine and tenofovir disoproxil fumarate
    69189-0701Truvadaemtricitabine and tenofovir disoproxil fumarate
    70518-0097Truvadaemtricitabine and tenofovir disoproxil fumarate
    72189-403TruvadaEmtricitabine/TDF

    Trademark Results [Truvada]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TRUVADA
    TRUVADA
    78239720 2915213 Live/Registered
    Gilead Sciences, Inc.
    2003-04-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.